Insider Transactions in Q2 2024 at Rocket Pharmaceuticals, Inc. (RCKT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2024
|
John Militello |
SELL
Open market or private sale
|
Direct |
1,079
-1.98%
|
$24,817
$23.35 P/Share
|
|
May 16
2024
|
Martin Wilson General Counsel |
SELL
Open market or private sale
|
Direct |
1,048
-1.57%
|
$24,104
$23.35 P/Share
|
|
May 16
2024
|
Gaurav Shah CEO |
SELL
Open market or private sale
|
Direct |
9,790
-1.33%
|
$225,170
$23.35 P/Share
|
|
May 16
2024
|
Kinnari Patel |
SELL
Open market or private sale
|
Direct |
4,046
-1.0%
|
$93,058
$23.35 P/Share
|
|
May 14
2024
|
Martin Wilson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,420
+10.29%
|
-
|
|
May 14
2024
|
Gaurav Shah CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,662
+1.36%
|
-
|
|
May 14
2024
|
Kinnari Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,543
+1.57%
|
-
|
|
May 02
2024
|
David P Southwell |
SELL
Bona fide gift
|
Indirect |
59,716
-34.55%
|
-
|
|
May 02
2024
|
David P Southwell |
SELL
Bona fide gift
|
Direct |
113,124
-98.55%
|
-
|
|
Apr 22
2024
|
John Militello |
SELL
Open market or private sale
|
Direct |
833
-1.51%
|
$18,326
$22.87 P/Share
|
|
Apr 15
2024
|
David P Southwell |
SELL
Open market or private sale
|
Direct |
10,000
-8.01%
|
$240,000
$24.05 P/Share
|
|
Apr 15
2024
|
David P Southwell |
BUY
Exercise of conversion of derivative security
|
Direct |
29,624
+19.19%
|
$118,496
$4.34 P/Share
|
|
Apr 12
2024
|
David P Southwell |
SELL
Open market or private sale
|
Direct |
70,000
-22.95%
|
$1,680,000
$24.69 P/Share
|
|
Apr 12
2024
|
David P Southwell |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+29.77%
|
$280,000
$4.34 P/Share
|
|
Apr 08
2024
|
Mark Andrew White |
SELL
Open market or private sale
|
Direct |
12,532
-14.28%
|
$300,768
$24.64 P/Share
|
|
Apr 01
2024
|
Aaron Ondrey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,781
+50.0%
|
-
|